Furthermore, the Honolulu-Asia aging study revealed that diabetes elevates the risk of developing AD in ApoE4 carriers compared to an isolated effect of ApoE4 without a diabetic condition (5.5 vs. 1.7 folds) (Peila et al., 2002). Here, APOE is linked to Alzheimer disease.